Development of a docetaxel micellar formulation using poly(ethylene glycol)–polylactide–poly(ethylene glycol) (PEG–PLA–PEG) with successful reconstitution for tumor targeted drug delivery

References

• Abdelwahed W, Degobert G, Stainmesse S, Fessi H. (2006). Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev 58:1688–713.
   PubMed Web of Science ®Google Scholar
• Adams ML, Lavasanifar A, Kwon GS. (2003). Amphiphilic block copolymers for drug delivery. J Pharm Sci 92:1343–55.
   PubMed Web of Science ®Google Scholar
• Allen C, Maysinger D, Eisenberg A. (1999). Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf B Biointerfaces 16:3–27.
   Web of Science ®Google Scholar
• Allison SD, Molina MDC, Anchordoquy TJ. (2000). Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis. Biochim Biophys Acta Biomembr 1468:127–38.
   PubMed Web of Science ®Google Scholar
• Allison SD, Randolph TW, Manning MC, et al. (1998). Effects of drying methods and additives on structure and function of actin: mechanisms of dehydration-induced damage and its inhibition. Arch Biochem Biophys 358:171–81.
   PubMed Web of Science ®Google Scholar
• Bertrand N, Wu J, Xu X, et al. (2014). Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev 66:2–25.
   PubMed Web of Science ®Google Scholar
• Carale TR, Pham QT, Blankschtein D. (1994). Salt effects on intramicellar interactions and micellization of nonionic surfactants in aqueous solutions. Langmuir 10:109–21.
   Web of Science ®Google Scholar
• Chen C, Han D, Cai C, Tang X. (2010). An overview of liposome lyophilization and its future potential. J Control Release 142:299–311.
   PubMed Web of Science ®Google Scholar
• Choi JY, Thapa RK, Yong CS, Kim JO. (2016). Nanoparticle-based combination drug delivery systems for synergistic cancer treatment. J Pharm Investig 46:325–39.
   Google Scholar
• Choi YH, Han H-K. (2018). Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics. J Pharm Investig 48:43–60.
   PubMedGoogle Scholar
• Crowe JH, Leslie SB, Crowe LM. (1994). Is vitrification sufficient to preserve liposomes during freeze-drying? Cryobiology 31:355–66.
   PubMed Web of Science ®Google Scholar
• Danhier F. (2016). To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine? J Control Release 244:108–21.
   PubMed Web of Science ®Google Scholar
• De Jaeghere F, Allémann E, Leroux J-C, et al. (1999). Formulation and lyoprotection of poly (lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake. Pharm Res 16:859–66.
   PubMed Web of Science ®Google Scholar
• Duncan R. (2003). The dawning era of polymer therapeutics. Nat Rev Drug Discov 2:347–60.
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. (2011). The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63:136–51.
   PubMed Web of Science ®Google Scholar
• Fonte P, Reis S, Sarmento B. (2016). Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery. J Control Release 225:75–86.
   PubMed Web of Science ®Google Scholar
• Gao X, Huang Y, Makhov AM, et al. (2012). Nanoassembly of surfactants with interfacial drug-interactive motifs as tailor-designed drug carriers. Mol Pharmaceutics 10:187–98.
   PubMed Web of Science ®Google Scholar
• Gaucher G, Dufresne MH, Sant VP, et al. (2005). Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release 109:169–88.
   PubMed Web of Science ®Google Scholar
• Hillaireau H, Couvreur P. (2009). Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci 66:2873–96.
   PubMed Web of Science ®Google Scholar
• Hoang NH, Lim C, Sim T, et al. (2016). Characterization of a triblock copolymer, poly (ethylene glycol)-polylactide-poly (ethylene glycol), with different structures for anticancer drug delivery applications. Polym Bull 74:1595–1609.
   Web of Science ®Google Scholar
• Hoang NH, Lim C, Sim T, et al. (2017a). Characterization of a triblock copolymer, poly(ethylene glycol)-polylactide-poly(ethylene glycol), with different structures for anticancer drug delivery applications. Polym Bull 74:1595–609.
   Web of Science ®Google Scholar
• Hoang NH, Lim C, Sim T, Oh KT. (2017b). Triblock copolymers for nano-sized drug delivery systems. J Pharm Investig 47:27–35.
   Google Scholar
• Jain NJ, George A, Bahadur P. (1999). Effect of salt on the micellization of pluronic P65 in aqueous solution. Colloids Surf A Physicochem Eng Asp 157:275–83.
   Web of Science ®Google Scholar
• Kataoka K, Harada A, Nagasaki Y. (2001). Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 47:113–31.
   PubMed Web of Science ®Google Scholar
• Kwag DS, Oh KT, Lee ES. (2014). Facile synthesis of multilayered polysaccharidic vesicles. J Control Release 187:83–90.
   PubMed Web of Science ®Google Scholar
• Maeda H. (2001). The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41:189–207.
   PubMedGoogle Scholar
• Maeda H, Wu J, Sawa T, et al. (2000). Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65:271–84.
   PubMed Web of Science ®Google Scholar
• Mata JP, Majhi PR, Guo C, et al. (2005). Concentration, temperature, and salt-induced micellization of a triblock copolymer Pluronic L64 in aqueous media. J Colloid Interface Sci 292:548–56.
   PubMed Web of Science ®Google Scholar
• Nampoothiri KM, Nair NR, John RP. (2010). An overview of the recent developments in polylactide (PLA) research. Bioresour Technol 101:8493–501.
   PubMed Web of Science ®Google Scholar
• Oh JK. (2011). Polylactide (PLA)-based amphiphilic block copolymers: synthesis, self-assembly, and biomedical applications. Soft Matter 7:5096–108.
   Web of Science ®Google Scholar
• Oh KT, Lee ES, Kim D, Bae YH. (2008). l-Histidine-based pH-sensitive anticancer drug carrier micelle: reconstitution and brief evaluation of its systemic toxicity. Int J Pharm 358:177–83.
   PubMed Web of Science ®Google Scholar
• Oh NM, Oh KT, Youn YS, et al. (2013). Poly(L-aspartic acid) nanogels for lysosome-selective antitumor drug delivery. Colloids Surf B Biointerfaces 101:298–306.
   PubMed Web of Science ®Google Scholar
• Oh NM, Oh KT, Youn YS, Lee ES. (2014). Artificial nano-pin as a temporal molecular glue for the targeting of acidic tumor cells. Polym Adv Technol 25:842–50.
   Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, et al. (2007). Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751.
   PubMed Web of Science ®Google Scholar
• Picco AS, Ferreira LF, Liberato MS, et al. (2018). Freeze-drying of silica nanoparticles: redispersibility toward nanomedicine applications. Nanomedicine 13:179–90.
   PubMed Web of Science ®Google Scholar
• Qi D, Gong F, Teng X, et al. (2017). Design and evaluation of mPEG-PLA micelles functionalized with drug-interactive domains as improved drug carriers for docetaxel delivery. J Biomater Sci Polym Ed 28:1538–55.
   PubMed Web of Science ®Google Scholar
• Qureshi OS, Kim H-S, Zeb A, et al. (2017). Sustained release docetaxel-incorporated lipid nanoparticles with improved pharmacokinetics for oral and parenteral administration. J Microencapsul 34:250–61.
   PubMed Web of Science ®Google Scholar
• Rasal RM, Janorkar AV, Hirt DE. (2010). Poly (lactic acid) modifications. Prog Polymer Sci 35:338–56.
   Web of Science ®Google Scholar
• Rösler A, Vandermeulen GW, Klok H-A. (2001). Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv Drug Deliv Rev 53:95–108.
   PubMed Web of Science ®Google Scholar
• Sandhu PS, Beg S, Mehta F, et al. (2015). Novel dietary lipid-based self-nanoemulsifying drug delivery systems of paclitaxel with p-gp inhibitor: implications on cytotoxicity and biopharmaceutical performance. Expert Opin Drug Deliv 12:1809–22.
   PubMed Web of Science ®Google Scholar
• Schver GCRM, Lee PI. (2018). Combined effects of supersaturation rates and doses on the kinetic-solubility profiles of amorphous solid dispersions based on water-insoluble Poly(2-hydroxyethyl methacrylate) hydrogels. Mol Pharmaceutics 15:2017–26.
   PubMed Web of Science ®Google Scholar
• Shi J, Kantoff PW, Wooster R, Farokhzad OC. (2017). Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer 17:20–37.
   PubMed Web of Science ®Google Scholar
• Shuai X, Ai H, Nasongkla N, et al. (2004). Micellar carriers based on block copolymers of poly(ε-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J Control Release 98:415–26.
   PubMed Web of Science ®Google Scholar
• Song H-T, Hoang NH, Yun JM, et al. (2016). Development of a new tri-block copolymer with a functional end and its feasibility for treatment of metastatic breast cancer. Colloids Surf B Biointerfaces 144:73–80.
   PubMed Web of Science ®Google Scholar
• Su C-Y, Liu J-J, Ho Y-S, et al. (2018). Development and characterization of docetaxel-loaded lecithin-stabilized micellar drug delivery system (LsbMDDs) for improving the therapeutic efficacy and reducing systemic toxicity. Eur J Pharm Biopharm 123:9–19.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. (2007). Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 24:1–16.
   PubMed Web of Science ®Google Scholar
• Van Vlerken LE, Vyas TK, Amiji MM. (2007). Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res 24:1405–14.
   PubMed Web of Science ®Google Scholar
• Wicki A, Witzigmann D, Balasubramanian V, Huwyler J. (2015). Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J Control Release 200:138–57.
   PubMed Web of Science ®Google Scholar
• Xie T, Gao W, Taylor LS. (2017). Impact of Eudragit EPO and hydroxypropyl methylcellulose on drug release rate, supersaturation, precipitation outcome and redissolution rate of indomethacin amorphous solid dispersions. Int J Pharm 531:313–23.
   PubMed Web of Science ®Google Scholar
• Yamaoka T, Tabata Y, Ikada Y. (1994). Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. J Pharm Sci 83:601–6.
   PubMed Web of Science ®Google Scholar
• Zambaux M, Bonneaux F, Gref R, et al. (1999). MPEO-PLA nanoparticles: effect of MPEO content on some of their surface properties. J Biomed Mater Res 44:109–15.
   PubMed Web of Science ®Google Scholar
• Zhang P, Lu J, Huang Y, et al. (2014). Design and evaluation of a PEGylated lipopeptide equipped with drug-interactive motifs as an improved drug carrier. AAPS J 16:114–24.
   PubMed Web of Science ®Google Scholar